We are Sorry, This Page doesn't Exist

There are 10 160 IPOs expected to price this week 160 after the July holiday slowdown The week is being led by oil and gas OEM AFG Holdings and Canadian cannabis supplier Tilray Six healthcare companies are also pricing this week with two 100 mm deals.....»»

The flood of initial public offerings is expected to slow to a trickle this week, as the August lull sets in and issuers pull back ahead of the Labor Day holiday weekend, but stalling Chinese internet stocks are also weighing......»»

One biotech Aridis Pharmaceu.....»»

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In.....»»

U.S. IPO Week Ahead: One SPAC Expected To Price During The Thick Of The Annual August Slowdown.....»»

Biotech stocks reversed course in the week ended April 16, with the sector re.....»»

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vac.....»»

U.S. oil futures finished lower on Thursday as traders awaited weekly data from the Energy Information Administration, which was delayed to Friday due to the Martin Luther King, Jr. holiday early this week and Wednesday's U.S. presidential inauguration. .....»»

Biotech stocks advanced for a third straight week, defying the broader market weakness. The space got solid support from positive stock reactions to presentations made at hematology and breast cancer conferences. read more.....»»

A week packed with U.S. economic data is likely to provide investors with more evidence of the extent to which the coronavirus pandemic has hit growth, sharpening the debate on whether a rebound in stocks has been justified amid an unprecedented slowdown......»»

U.S. stock index futures retreated on Wednesday for a second time this week, as a slide in oil prices pressured energy stocks ahead of what is expected to be another dismal round of first-quarter earnings reports......»»

U.S. stocks opened slightly lower on Monday, as weak data from China rekindled fears of a slowdown in the world's second-biggest economy, while investors looked for any positive news on trade talks ahead of a tariff deadline later in the week......»»

U.S. stocks were set to open lower on Monday as weak data from China brought back fears of a slowdown in the world's second-biggest economy, while investors looked for any positive news on trade talks ahead of a tariff deadline later in the week......»»

Oil prices were mixed on Monday with traders pegging cautious hopes for a rebound from last week's losses on progress in talks on ending the U.S.-China trade war, against a backdrop of global economic slowdown weighing on future oil demand......»»

Notwithstanding the ESMO conference generating some huge moves in some stocks, last week turned out to be a muted one for biotechs. read more.....»»

Biotech stocks came under selling pressure in the week ended Sept. 27 amid clinical data readouts and a handful of FDA decisions. read more.....»»

Overbought markets "tend to get hit with sell-offs, especially when we're being flooded with shoddy IPOs," Jim Cramer says......»»

Biotech stocks rebounded in last week after declining modestly in the previous week. read more.....»»

A decline in interest rates on long-term U.S. government bonds below the average stock dividend yield has received less attention than an inverted Treasury yield curve, but it could be a reason stocks find support after a bruising August......»»